Biomarker potential of heme oxygenase-1 in Alzheimer's disease and mild cognitive impairment

被引：20

作者：

Schipper, Hyman M. ^{[1
]}

机构：

[1] McGill Univ, Sir Mortimer B Davis Jewish Hosp, Ctr Neurotranslat Res, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada

来源：

BIOMARKERS IN MEDICINE | 2007年 / 1卷 / 03期

关键词：

alpha; 1-antitrypsin; Alzheimer's disease; biomarker; cerebrospinal fluid; heme oxygenase-1; mild cognitive impairment; plasma;

D O I：

10.2217/17520363.1.3.375

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

The advent of an accessible chemical biological marker that differentiates early, sporadic Alzheimer's disease (AD) from normal aging and other dementing illnesses, and identifies individuals with mild cognitive impairment who are destined to deteriorate to Alzheimer's dementia, would represent a major achievement in the evaluation and management of this common neurodegenerative disorder. Although several candidate biomarkers of sporadic AD have been identified and commercialized, none currently fulfill the criteria for an ideal test. In this article, we review evidence implicating blood heme oxygenase-1 mRNA/protein levels and a recently identified plasma heme oxygenase-1 suppressor factor as potential biomarkers of AD and mild cognitive impairment.

引用

页码：375 / 385

页数：11

共 47 条

[11] DIFFERENTIAL-EFFECTS OF CYSTEAMINE ON HEAT-SHOCK PROTEIN INDUCTION AND CYTOPLASMIC GRANULATION IN ASTROCYTES AND GLIOMA-CELLS [J].

CHOPRA, VS ;

CHALIFOUR, LE ;

SCHIPPER, HM .

MOLECULAR BRAIN RESEARCH, 1995, 31 (1-2) :173-184

[12] Alpha-1-antitrypsin and a broad spectrum metalloprotease inhibitor, RS113456, have similar acute anti-inflammatory effects [J].

Churg, A ;

Dai, J ;

Zay, K ;

Karsan, A ;

Hendricks, R ;

Yee, C ;

Martin, R ;

MacKenzie, R ;

Xie, CS ;

Zhang, L ;

Shapiro, S ;

Wright, JL .

LABORATORY INVESTIGATION, 2001, 81 (08) :1119-1131

[13]

Dennery PA, 2000, CURR TOP CELL REGUL, V36, P181

[14] Serum inflammatory proteins and cognitive decline in older persons [J].

Dik, MG ;

Jonker, C ;

Hack, CE ;

Smit, JH ;

Comijs, HC ;

Eikelenboom, P .

NEUROLOGY, 2005, 64 (08) :1371-1377

[15] Association of elevated α1-antichymotrypsin with cognitive impairment in a prospective study of the very old [J].

Gabriel, SM ;

Marin, DB ;

Aisen, PS ;

Lantz, M ;

Altstiel, LD ;

Davis, KL ;

Mohs, RC .

AMERICAN JOURNAL OF PSYCHIATRY, 1998, 155 (05) :698-700

[16] ALPHA-1-ANTITRYPSIN AND ALPHA-1-ANTICHYMOTRYPSIN ARE IN THE LESIONS OF ALZHEIMERS-DISEASE [J].

GOLLIN, PA ;

KALARIA, RN ;

EIKELENBOOM, P ;

ROZEMULLER, A ;

PERRY, G .

NEUROREPORT, 1992, 3 (02) :201-203

[17]

Ham D, 2000, CELL MOL BIOL, V46, P587

[18] Possible assessment for antioxidant capacity in Alzheimer's disease by measuring lymphocyte heme oxygenase-1 expression with real-time RT-PCR [J].

Ishizuka, K ;

Kimura, T ;

Yoshitake, J ;

Akaike, T ;

Shono, M ;

Takamatsu, J ;

Katsuragi, S ;

Kitamura, T ;

Miyakawa, T .

ALZHEIMER'S DISEASE: VASCULAR ETIOLOGY AND PATHOLOGY, 2002, 977 :173-178

[19] Microsatellite polymorphism in the human heme oxygenase-1 gene promoter and its application in association studies with Alzheimer and Parkinson disease [J].

Kimpara, T ;

Takeda, A ;

Watanabe, K ;

Itoyama, Y ;

Ikawa, S ;

Watanabe, M ;

Arai, H ;

Sasaki, H ;

Higuchi, S ;

Okita, N ;

Takase, S ;

Saito, H ;

Takahashi, K ;

Shibahara, S .

HUMAN GENETICS, 1997, 100 (01) :145-147

[20] Bach1 functions as a hypoxia-inducible repressor for the heme oxygenase-1 gene in human cells [J].

Kitamuro, T ;

Takahashi, K ;

Ogawa, K ;

Udono-Fujimori, R ;

Takeda, K ;

Furuyama, K ;

Nakayama, M ;

Sun, JY ;

Fujita, H ;

Hida, W ;

Hattori, T ;

Shirato, K ;

Igarashi, K ;

Shibahara, S .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (11) :9125-9133

← 1 2 3 4 5 →